Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study.
Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study.
复制标题
血管紧张素 II 1 型受体阻滞剂可降低高血压患者的组织因子活性和纤溶酶原激活剂抑制剂 1 型抗原:一项随机、双盲、安慰剂对照研究。
作者:
K. Koh;W. Chung;J. Ahn;S. Han;W. Kang;Y. Seo;T. Ahn;I. S. Choi;E. Shin
影响因子:
37.8
作者:
Badimon, JJ;Lettino, M;Badimon, L
通讯作者:
Badimon, L
影响因子:
37.8
作者:
L. Oltrona;C. M. Speidel;D. Recchia;S. Wickline;P. Eisenberg;D. Abendschein
通讯作者:
L. Oltrona;C. M. Speidel;D. Recchia;S. Wickline;P. Eisenberg;D. Abendschein
影响因子:
37.8
作者:
Laursen, JB;Rajagopalan, S;Harrison, DG
通讯作者:
Harrison, DG